World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Biology and Biochemistry
Canada
2026

D-Index & Metrics

Best Scientists

D-Index
167
Citations
103835
World Ranking
978
National Ranking
21

Biology and Biochemistry

D-Index
169
Citations
105199
World Ranking
93
National Ranking
4

Medicine

D-Index
169
Citations
105312
World Ranking
544
National Ranking
13

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Canada Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Biology and Biochemistry in Canada Leader Award
  • 2023 - Research.com Biology and Biochemistry in Canada Leader Award
  • 2023 - Research.com Medicine in Canada Leader Award
  • 2022 - Research.com Biology and Biochemistry in Canada Leader Award
  • 2011 - Izaak Walton Killam Memorial Prize, Canada Council
  • 2011 - Canada Gairdner Wightman Award
  • 1995 - Fellow of the Royal Society of Canada Academy of Science

Overview

Michael R. Hayden is affiliated with the University of British Columbia in Canada, focusing on research that spans biochemistry, genetics, molecular biology, neuroscience, and medicine. Their work mainly addresses genetic neurodegenerative diseases and explores molecular and cellular mechanisms underlying neurological disorders.

The primary fields of study for this researcher include:

  • Biochemistry, Genetics and Molecular Biology
  • Neuroscience
  • Medicine

Within these domains, their subfields of study concentrate on:

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Neurology
  • Genetics
  • Oncology

Key topics covered in their publications involve:

  • Genetic Neurodegenerative Diseases
  • Mitochondrial Function and Pathology
  • Neurological disorders and treatments
  • Pharmacological Receptor Mechanisms and Effects
  • Neuroscience and Neuropharmacology Research
  • Muscle Physiology and Disorders
  • Amyotrophic Lateral Sclerosis Research

Their publication record includes frequent appearances in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology
  • Neurobiology of Disease
  • Journal of Huntington's Disease
  • Neurotherapeutics

Michael R. Hayden has collaborated extensively with several researchers including:

  • Michal Geva
  • Nicholas S. Caron
  • Hailey Findlay Black
  • Blair R. Leavitt
  • Amber L. Southwell

Among recent research publications, notable papers are:

  • Small molecule splicing modifiers with systemic HTT-lowering activity, 2021, Nature Communications
  • Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies, 2020, The Lancet Neurology
  • Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease, 2020, Journal of Neuroscience
  • The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models, 2021, Neurotherapeutics
  • Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine, 2022, Autophagy

The researcher's recognition includes awards such as the Izaak Walton Killam Memorial Prize by the Canada Council in 2011, the Canada Gairdner Wightman Award also in 2011, and election as a Fellow of the Royal Society of Canada in 1995 within the Academy of Science.

Best Publications

  • Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

    A. Brooks-Wilson;M. Marcil;S. M. Clee;L.-H. Zhang

  • Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

    Chiara Zuccato;Andrea Ciammola;Dorotea Rigamonti;Blair R. Leavitt

  • Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

    Alexander V. Panov;Claire-Anne Gutekunst;Blair R. Leavitt;Michael R. Hayden

  • Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.

    George Papanikolaou;Mark E Samuels;Erwin H Ludwig;Marcia L E MacDonald

  • Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.

    Chiara Zuccato;Marzia Tartari;Andrea Crotti;Donato Goffredo

  • Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.

    Jamal Nasir;Stan B Floresco;John R O'Kusky;Virginia M Diewert

  • A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

    J.Graeme Hodgson;Nadia Agopyan;Claire-Anne Gutekunst;Blair R Leavitt

  • Detection of Huntington’s disease decades before diagnosis: The Predict HD study

    Jane Paulsen;Douglas R Langbehn;Julie C Stout;Elizabeth H Aylward

  • Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease

    Elizabeth J. Slow;Jeremy van Raamsdonk;Daniel Rogers;Sarah H. Coleman

  • A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

    Douglas R. Langbehn;Ryan R. Brinkman;Daniel Falush;Jane S. Paulsen

  • Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force

    Michael Hayden;Michael Pignone;Christopher Phillips;Cynthia Mulrow

  • A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.

    Shinji Hadano;Collette K. Hand;Hitoshi Osuga;Yoshiko Yanagisawa

  • Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.

    Rona K. Graham;Yu Deng;Elizabeth J. Slow;Brendan Haigh

  • Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.

    Y.P. Goldberg;D.W. Nicholson;D.M. Rasper;M.A. Kalchman

  • A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

    Maria Björkqvist;Edward J. Wild;Jenny Thiele;Aurelio Silvestroni

  • Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease.

    Melinda M Zeron;Oskar Hansson;Nansheng Chen;Cheryl L Wellington

  • Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.

    Rubinsztein Dc;Leggo J;Coles R;Almqvist E

  • Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract

    Cheryl L. Wellington;Lisa M. Ellerby;Abigail S. Hackam;Russell L. Margolis

  • Huntington's Chorea

    P Beighton;M R Hayden

  • Mutations in ABC1 in Tangier disease and familial high-density lipoprotein

    A Brooks-Wilson;Michel Marcil;Susanne M. Clee;Lin-Hua Zhang

Frequent Co-Authors

Roshni R. Singaraja
Roshni R. Singaraja Agency for Science, Technology and Research
Blair R. Leavitt
Blair R. Leavitt University of British Columbia
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Rona K. Graham
Rona K. Graham Université de Sherbrooke
Lynn A. Raymond
Lynn A. Raymond University of British Columbia
Christopher A. Ross
Christopher A. Ross Johns Hopkins University School of Medicine
Marcy E. MacDonald
Marcy E. MacDonald Harvard University
John D. Brunzell
John D. Brunzell University of Washington
Jane S. Paulsen
Jane S. Paulsen University of Wisconsin–Madison
Donald W. Nicholson
Donald W. Nicholson MSD (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Michael R. Hayden

Trending Scientists

Recently Published Articles